May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
DNA polymerase and ß expression selectively localized to photoreceptors is down regulated by LAU–0901, coinciding with light–damage protection
Author Affiliations & Notes
  • M.S. Cortina
    Ophthalmology/Neuroscience, LSU Health Sciences Center, New Orleans, LA
  • W.J. Lukiw
    Ophthalmology/Neuroscience, LSU Health Sciences Center, New Orleans, LA
  • D.R. Bergsma
    Ophthalmology/Neuroscience, LSU Health Sciences Center, New Orleans, LA
  • W.C. Gordon
    Ophthalmology/Neuroscience, LSU Health Sciences Center, New Orleans, LA
  • N.G. Bazan
    Ophthalmology/Neuroscience, LSU Health Sciences Center, New Orleans, LA
  • Footnotes
    Commercial Relationships  M.S. Cortina, None; W.J. Lukiw, None; D.R. Bergsma, None; W.C. Gordon, None; N.G. Bazan, None.
  • Footnotes
    Support  NIH Grant R01EY05121, Neurobiotech Program LA
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 774. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.S. Cortina, W.J. Lukiw, D.R. Bergsma, W.C. Gordon, N.G. Bazan; DNA polymerase and ß expression selectively localized to photoreceptors is down regulated by LAU–0901, coinciding with light–damage protection . Invest. Ophthalmol. Vis. Sci. 2004;45(13):774.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: In bright light–induced photoreceptor apoptosis mtDNA is affected first, triggering the upregulation of a repair response involving DNA polymerase γ. nDNA fragmentation follows about 18 hours later, followed by DNA polymerase ß induction, in an attempt to repair damaged nuclear DNA. However, this light–evoked photoreceptor repair is only partially successful. LAU–0901, a PAF receptor antagonist, has been shown to have neuroprotective activity in the retina under our experimental conditions. The purpose of this study is to explore action/s effects of LAU–0901 on the photoreceptor apoptotic pathway. Methods: Sprague Dawley rats, dark–adapted 2d, were light–treated for 5h and returned to darkness (light controls). 2h prior to light exposure, some rats were treated with LAU–0901 (1µl/gr bw, IP). Eyes were collected 6 and 24h after light. Right retinas were analyzed by Western blot for DNA polymerase γ and ß. Left eyes were fixed, cryoprotected, and sectioned for TUNEL labeling. The total number of TUNEL–positive photoreceptor nuclei were counted in sections cut from the superior to the inferior margins of each retina and averaged. Results: LAU–0901 decreased the number of TUNEL–positive photoreceptor nuclei (cells with fragmented DNA) by 70%. Western blot analysis showed a decrease of 66% in light–induced upregulation of DNA polymerase γ in LAU–0901 treated animals compared to others that had not received the drug. Dark controls injected with LAU–0901 showed an upregulation of DNA polymerase γ of 50% over non–treated animals. Conclusions: Treatment with LAU–0901 protects photoreceptors when exposed to bright light. Nuclear DNA fragmentation is considerably reduced. DNA polymerase γ is also decreased in treated animals suggesting that mtDNA is protected. These data suggest that LAU–0901 acts very early in the apoptotic pathway, probably at the mitochondrial level. It is also possible that LAU–0901 selectively upregulates DNA polymerase γ. As a result, mitochondrial function is preserved and photoreceptor survival is enhanced. (LAU–0901 patent assignee LSUHSC)

Keywords: neuroprotection • mitochondria • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×